Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clinical Infectious Diseases
2008; 46: S4–S11.
Karlstrom O, et al.
A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clinical Infectious Diseases
1998; 26: 141–145.
Noren T, et al.
Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. Journal of Clinical Microbiology
2004; 42: 3635–3643.
Søes LM, et al.
Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients. European Journal of Clinical Microbiology and Infectious Diseases
2012; 31: 185–192.
Wilcox MH, et al.
A case-control study of community-associated Clostridium difficile infection. Journal of Antimicrobial Chemotherapy
2008; 62: 388–396.
Gould LH, Limbago B. Food Safety: Clostridium difficile in food and domestic animals: a new foodborne pathogen?
Clinical Infectious Diseases
2010; 51: 577–582.
Keessen EC, Gaastra W, Lipman LJA.
Clostridium difficile infection in humans and animals, differences and similarities. Veterinary Microbiology
2011; 153: 205–217.
Rodriguez-Palacios A, et al.
Clostridium difficile PCR ribotypes in calves, Canada. Emerging Infectious Diseases
2006; 12: 1730–1736.
Rodriguez-Palacios A, et al.
Clostridium difficile in retail ground meat, Canada. Emerging Infectious Diseases
2007; 13: 485–487.
Von Abercron SM, et al.
Low occurrence of Clostridium difficile in retail ground meat in Sweden. Journal of Food Protection
2009; 72: 1732–1734.
Borriello SP, et al.
Household pets as a potential reservoir for Clostridium difficile infection. Journal of Clinical Pathology
1983; 36: 84–87.
Weese JS, et al.
Evaluation of Clostridium difficile in dogs and the household environment. Epidemiology and Infection
2010; 138: 1100–1104.
Yearsley KA, et al.
Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Alimentary Pharmacology & Therapeutics
2006; 24: 613–619.
Kuntz J, et al.
Incidence of and Risk Factors for Community-associated Clostridium difficile Infection: a nested case-control study. BMC Infectious Diseases
2011; 11: 194.
Dial S, et al.
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. Journal of American Medical Association
2005; 294: 2989–2995.
Hensgens MPM, et al.
Clostridium difficile infection in an endemic setting in the Netherlands. European Journal of Clinical Microbiology and Infectious Diseases
2011; 30: 587–593.
Naggie S, et al.
A Case-control Study of Community-associated Clostridium difficile Infection: No Role for Proton Pump Inhibitors. American Journal of Medicine
2011; 124: 276.
Bavishi C, DuPont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimentary Pharmacology & Therapeutics
2011; 34: 1269–1281.
Pépin J, Gonzales M, Valiquette L. Risk of secondary cases of Clostridium difficile infection among household contacts of index cases. Journal of Infection
2012; 64: 387–390.
Blom M, et al.
Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. Journal of Clinical Microbiology
1999; 37: 2312–2316.
Hutchinson DN, Bolton FJ. Improved blood free selective medium for the isolation of Campylobacter jejuni from faecal specimens. Journal of Clinical Pathology
1984; 37: 956–957.
Persson S, et al.
A method for fast and simple detection of major diarrhoeagenic Escherichia coli in the routine diagnostic laboratory. Clinical Microbiology and Infection
2007; 13: 516–524.
Kageyama T, et al.
Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. Journal of Clinical Microbiology
2003; 41: 1548–1557.
Johnsen CK, Midgley S, Böttiger B. Genetic diversity of sapovirus infections in Danish children 2005–2007. Journal of Clinical Virology
2009; 46: 265–269.
Pang XL, et al.
Increased detection of rotavirus using a real time reverse transcription-polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea. Journal of Medical Virology
2004; 72: 496–501.
Logan C, O'Leary JJ, O'Sullivan N. Real-time reverse transcription-PCR for detection of rotavirus and adenovirus as causative agents of acute viral gastroenteritis in children. Journal of Clinical Microbiology
2006; 44: 3189–3195.
Logan C, O'Leary JJ, O'Sullivan N. Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis. Journal of Virological Methods
2007; 146: 36–44.
Stensvold CR, Nielsen HV. Comparison of microscopy and PCR for detection of intestinal parasites in Danish patients supports an incentive for molecular screening platforms. Journal of Clinical Microbiology
2012; 50: 540–541.
Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clinical Microbiology and Infection
2008; 14: 1057–1064.
O'Neill GL, et al.
Modification of a PCR Ribotyping Method for Application as a Routine Typing Scheme for Clostridium difficile
1996; 2: 205–209.
Stubbs SL, et al.
PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. Journal of Clinical Microbiology
1999; 37: 461–463.
Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clinical Microbiology and Infection
2006; 12 (Suppl. 6): 2–18.
McDonald LC, et al.
Recommendations for surveillance of Clostridium difficile-associated disease. Infection Control and Hospital Epidemiology
2007; 28: 140–145.
Dial S, et al.
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. Canadian Medical Association Journal
2008; 179: 767–772.
Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. Journal of American Medical Association
2009; 301: 954–962.
Kutty PK, et al.
Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerging Infectious Diseases
2010; 16: 197–204.
Holst E, Helin I, Mardh PA. Recovery of Clostridium difficile from children. Scandinavian Journal of Infectious Diseases
1981; 13: 41–45.
Vesikari T, et al.
Clostridium difficile in young children. Association with antibiotic usage. Acta Paediatrica Scandinavica
1984; 73: 86–91.
Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology
1981; 81: 5–9.
Kim J, et al.
Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001–2006. Pediatrics
2008; 122: 1266–1270.
Zilberberg MD, Tillotson GS, McDonald C.
Clostridium difficile infections among hospitalized children, United States, 1997–2006. Emerging Infectious Diseases
2010; 16: 604–609.
Turco R, et al.
Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Alimentary Pharmacology and Therapeutics
2010; 31: 754–759.
Damborg P, et al.
Occurrence of Campylobacter jejuni in pets living with human patients infected with C. jejuni. Journal of Clinical Microbiology
2004; 42: 1363–1364.
Clostridium difficile: (re)emergence of zoonotic potential. Clinical Infectious Diseases
2010; 51: 583–584.
Keel K, et al.
Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. Journal of Clinical Microbiology
2007; 45: 1963–1964.
Goorhuis A, et al.
Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clinical Infectious Diseases
2008; 47: 1162–1170.